DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow DVA
DaVita Inc. (DVA) EV/EBITDA
As of 16 October 2026, DaVita Inc. (DVA) trades at a EV/EBITDA of 7.8×. Over the past ten years it has ranged from 5.6× (August 2017) to 13.1× (May 2015); the current reading is higher than 40% of that period. That is below the Medical Care Facilities industry median of 10.2× and below the Healthcare sector median of 9.2×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 6.6× | (12.90%) |
| FY2024 | 7.5× | 0.52% |
| FY2023 | 7.5× | 0.50% |
| FY2022 | 7.5× | (8.87%) |
| FY2021 | 8.2× | (11.92%) |
| FY2020 | 9.3× | 14.29% |
| FY2019 | 8.1× | (6.73%) |
| FY2018 | 8.7× | 0.61% |
| FY2017 | 8.7× | 12.26% |
| FY2016 | 7.7× | (37.65%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 8.6× | 18.91% |
| Mar 2026 | 7.2× | 10.35% |
| Dec 2025 | 6.6× | (5.16%) |
| Sep 2025 | 6.9× | (5.07%) |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 4.9× |
| UHS Universal Health Services, Inc. compare | 5.8× |
| THC Tenet Healthcare Corporation compare | 6.1× |
| DVA DaVita Inc. | 7.8× |
| EHC Encompass Health Corporation compare | 10.3× |
| CON Concentra Group Holdings Parent, Inc. compare | 13.6× |
| PACS PACS Group, Inc. compare | 15.6× |
| CHE Chemed Corporation compare | 16.5× |
| ENSG The Ensign Group, Inc. compare | 17.2× |
| Medical Care Facilities industry median | 10.2× |
| Healthcare sector median | 9.2× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on DVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement